Form 8-K - Current report:
SEC Accession No. 0001213900-25-055915
Filing Date
2025-06-20
Accepted
2025-06-20 10:52:42
Documents
14
Period of Report
2025-06-20
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246047-8k_kronos.htm   iXBRL 8-K 51122
2 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF KRONOS BIO, INC ea024604701ex3-1_kronos.htm EX-3.1 34298
3 SECOND AMENDED AND RESTATED BYLAWS OF KRONOS BIO, INC ea024604701ex3-2_kronos.htm EX-3.2 104816
  Complete submission text file 0001213900-25-055915.txt   397723

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE kron-20250620.xsd EX-101.SCH 3017
5 XBRL LABEL FILE kron-20250620_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE kron-20250620_pre.xml EX-101.PRE 22360
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0246047-8k_kronos_htm.xml XML 3801
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 251059582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)